Ertapenem
Ertapenem is a pharmaceutical drug with 44 clinical trials. Currently 3 active trials ongoing. Historical success rate of 89.3%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
9
Mid Stage
26
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
25 of 30 finished
16.7%
5 ended early
3
trials recruiting
44
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network
Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)
Clinical Trials (44)
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network
Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)
Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia
Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
Ertapenem Administered Subcutaneously Versus Intravenously
Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis
Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis
A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Antibiotic Prophylaxis in Patients Undergoing GVO
Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 44